Posted On: 11/20/2013 10:24:39 PM
Post# of 102422
$GALE Company News
Top longs and shorts to watch 12:18 p.m. March 6, 2012 - The Trading Deck
UNIS Stock Explodes By Nearly 50%, Slowing Its Race to the Bottom 8:45 a.m. Today - InvestorPlace.com
Investments On Biotech's Cutting Edge: Joseph Pantginis 4:41 p.m. Nov. 18, 2013 - Seeking Alpha
New Top Stocks to Buy Under $10 with Big Upside 7:16 a.m. Nov. 18, 2013 - 247WallSt.com
Galena: Positive Results Continue To Give This Stock Growth Potential 2:46 a.m. Nov. 17, 2013 - Seeking Alpha
10-Q: RXI PHARMACEUTICALS CORP 6:52 a.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
Galena Is Rallying On More Good News For Investors 2:26 p.m. Nov. 13, 2013 - Seeking Alpha
Tesla Is Talking Pickup Trucks, Netflix’s New Menu, and 3 More Hot Stocks 1:44 p.m. Nov. 13, 2013 - Wall St. Cheat Sheet
Will Galena Biopharma Triple Soon? 8:40 a.m. Nov. 12, 2013 - Wall St. Cheat Sheet
Galena Biopharma Announces Phase 1 Trial Showa Folate Binding Protein Vaccine is Safe and Immunogenic 6:08 a.m. Nov. 11, 2013 - benzinga.com
10-Q/A: GALENA BIOPHARMA, INC. 6:10 a.m. Nov. 7, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: GALENA BIOPHARMA, INC. 4:44 p.m. Nov. 6, 2013 - Edgar Online - (EDG = 10Q, 10K)
5 Short-Term Catalysts Make Galena Biopharma A Long-Term Buy 4:31 p.m. Nov. 2, 2013 - Seeking Alpha
2013 Biotech Watchlist Update: Companies Climb And Crumble On Catalysts 11:48 a.m. Nov. 1, 2013 - Seeking Alpha
Biotechnology: Finding The Best And Worst Value In The Industry 10:20 a.m. Oct. 30, 2013 - Seeking Alpha
Investments In Targeting HER2 For The Treatment Of Cancer 10:39 a.m. Oct. 28, 2013 - Seeking Alpha
First Week Of December 21st Options Trading For Galena Biopharma (GALE) 11:01 a.m. Oct. 25, 2013 - TheStreet.com
The Young And Restless Retirement Portfolio: A Focus On Zynga; Do Not Sell Before Or After The Earnings Report 2:14 p.m. Oct. 18, 2013 - Seeking Alpha
Will Lost Patents Force Roche Into Acquisition Mode? 12:44 p.m. Oct. 15, 2013 - Seeking Alpha
Team Alpha Growth And Income Retirement Portfolio: A Focus On Galena And The Potential For Very Strong Growth 2:24 p.m. Oct. 11, 2013 - Seeking Alpha
Galena: The Launch Of Abstral And Other Important Catalysts 1:16 p.m. Oct. 8, 2013 - Seeking Alpha
Quarterly Reports and Events - Research Report on Mettler-Toledo, Galena Biopharma, Achillion, Wright Medical, and OXiGENE 8:00 a.m. Nov. 15, 2013 - PR Newswire
ZLCS, CLRX, DSCO and GALE added to NASDAQ Active Stock Watch List at GSR 10:19 a.m. Nov. 11, 2013 - ACCESSWIRE
Galena Biopharma Announces Initial Results From the Folate Binding Protein Vaccine Phase 1 Trial at the Society for Immunotherapy of Cancer Conference 7:05 a.m. Nov. 11, 2013 - GlobeNewswire
Galena Biopharma Reports Third Quarter 2013 Results 4:35 p.m. Nov. 6, 2013 - GlobeNewswire
Closing of Over-Allotment Options, Receiving Orphan Drug Designations, Release of Clinical Data, and Obtaining Important Patents - Research Report on Galena, Zalicus, Infinity, Stemline and Insmed 8:00 a.m. Nov. 5, 2013 - PR Newswire
Morning Research: Ariad Pharma Inc., MannKind Corp., Novavax Inc., and Galena Biopharma Inc. 1:30 p.m. Nov. 1, 2013 - PR Newswire
New Small Cap Reports on RXII, APPA and TRTC 2:20 a.m. Nov. 1, 2013 - ACCESSWIRE
3 Reasons To Consider Investing In RXi Pharmaceuticals 10:17 a.m. Oct. 16, 2013 - ACCESSWIRE
Mentor Capital Cancer Immunotherapy Index Up 100% in 2013 8:03 a.m. Oct. 16, 2013 - BusinessWire
Pre-Market Review: MannKind Corp., Galena Biopharma Inc., Ariad Pharmaceuticals Inc., and Novavax Inc. 3:40 p.m. Oct. 10, 2013 - PR Newswire
Galena Biopharma Announces Oral Presentation at the American College of Surgeons Clinical Congress 2013 7:05 a.m. Oct. 7, 2013 - GlobeNewswire
Galena Biopharma to Present at the 12th Annual BIO Investor Forum 7:05 a.m. Oct. 4, 2013 - GlobeNewswire
Galena Biopharma Launches Abstral(R) (fentanyl) Sublingual Tablets for the Treatment of Breakthrough Cancer Pain 7:05 a.m. Oct. 3, 2013 - GlobeNewswire
Merger Updates, Milestone Payments, AGM Results, Review of Strategic Alternatives and Other Corporate Announcements - Research Report on Cubist, Halozyme, Taro, Galena and Sequenom 8:00 a.m. Oct. 1, 2013 - PR Newswire
Galena Biopharma Announces Closing of Over-Allotment Option, Increasing Total Gross Proceeds to $40 Million 3:22 p.m. Sept. 23, 2013 - GlobeNewswire
Galena Biopharma to Present at the 20th Annual NewsMakers in the Biotech Industry Conference 7:05 a.m. Sept. 23, 2013 - GlobeNewswire
Galena Biopharma Announces Closing of Public Offering of Common Stock and Warrants 12:52 p.m. Sept. 18, 2013 - GlobeNewswire
Five Star Equities Issues New Research Reports on DCTH, GALE, MKTO and NSPH 8:40 a.m. Sept. 16, 2013 - ACCESSWIRE
Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants 9:20 a.m. Sept. 13, 2013 - GlobeNewswire
Galena Biopharma Announces Proposed Public Offering of Common Stock and Warrants 4:05 p.m. Sept. 12, 2013 - GlobeNewswire
Top longs and shorts to watch 12:18 p.m. March 6, 2012 - The Trading Deck
UNIS Stock Explodes By Nearly 50%, Slowing Its Race to the Bottom 8:45 a.m. Today - InvestorPlace.com
Investments On Biotech's Cutting Edge: Joseph Pantginis 4:41 p.m. Nov. 18, 2013 - Seeking Alpha
New Top Stocks to Buy Under $10 with Big Upside 7:16 a.m. Nov. 18, 2013 - 247WallSt.com
Galena: Positive Results Continue To Give This Stock Growth Potential 2:46 a.m. Nov. 17, 2013 - Seeking Alpha
10-Q: RXI PHARMACEUTICALS CORP 6:52 a.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
Galena Is Rallying On More Good News For Investors 2:26 p.m. Nov. 13, 2013 - Seeking Alpha
Tesla Is Talking Pickup Trucks, Netflix’s New Menu, and 3 More Hot Stocks 1:44 p.m. Nov. 13, 2013 - Wall St. Cheat Sheet
Will Galena Biopharma Triple Soon? 8:40 a.m. Nov. 12, 2013 - Wall St. Cheat Sheet
Galena Biopharma Announces Phase 1 Trial Showa Folate Binding Protein Vaccine is Safe and Immunogenic 6:08 a.m. Nov. 11, 2013 - benzinga.com
10-Q/A: GALENA BIOPHARMA, INC. 6:10 a.m. Nov. 7, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: GALENA BIOPHARMA, INC. 4:44 p.m. Nov. 6, 2013 - Edgar Online - (EDG = 10Q, 10K)
5 Short-Term Catalysts Make Galena Biopharma A Long-Term Buy 4:31 p.m. Nov. 2, 2013 - Seeking Alpha
2013 Biotech Watchlist Update: Companies Climb And Crumble On Catalysts 11:48 a.m. Nov. 1, 2013 - Seeking Alpha
Biotechnology: Finding The Best And Worst Value In The Industry 10:20 a.m. Oct. 30, 2013 - Seeking Alpha
Investments In Targeting HER2 For The Treatment Of Cancer 10:39 a.m. Oct. 28, 2013 - Seeking Alpha
First Week Of December 21st Options Trading For Galena Biopharma (GALE) 11:01 a.m. Oct. 25, 2013 - TheStreet.com
The Young And Restless Retirement Portfolio: A Focus On Zynga; Do Not Sell Before Or After The Earnings Report 2:14 p.m. Oct. 18, 2013 - Seeking Alpha
Will Lost Patents Force Roche Into Acquisition Mode? 12:44 p.m. Oct. 15, 2013 - Seeking Alpha
Team Alpha Growth And Income Retirement Portfolio: A Focus On Galena And The Potential For Very Strong Growth 2:24 p.m. Oct. 11, 2013 - Seeking Alpha
Galena: The Launch Of Abstral And Other Important Catalysts 1:16 p.m. Oct. 8, 2013 - Seeking Alpha
Quarterly Reports and Events - Research Report on Mettler-Toledo, Galena Biopharma, Achillion, Wright Medical, and OXiGENE 8:00 a.m. Nov. 15, 2013 - PR Newswire
ZLCS, CLRX, DSCO and GALE added to NASDAQ Active Stock Watch List at GSR 10:19 a.m. Nov. 11, 2013 - ACCESSWIRE
Galena Biopharma Announces Initial Results From the Folate Binding Protein Vaccine Phase 1 Trial at the Society for Immunotherapy of Cancer Conference 7:05 a.m. Nov. 11, 2013 - GlobeNewswire
Galena Biopharma Reports Third Quarter 2013 Results 4:35 p.m. Nov. 6, 2013 - GlobeNewswire
Closing of Over-Allotment Options, Receiving Orphan Drug Designations, Release of Clinical Data, and Obtaining Important Patents - Research Report on Galena, Zalicus, Infinity, Stemline and Insmed 8:00 a.m. Nov. 5, 2013 - PR Newswire
Morning Research: Ariad Pharma Inc., MannKind Corp., Novavax Inc., and Galena Biopharma Inc. 1:30 p.m. Nov. 1, 2013 - PR Newswire
New Small Cap Reports on RXII, APPA and TRTC 2:20 a.m. Nov. 1, 2013 - ACCESSWIRE
3 Reasons To Consider Investing In RXi Pharmaceuticals 10:17 a.m. Oct. 16, 2013 - ACCESSWIRE
Mentor Capital Cancer Immunotherapy Index Up 100% in 2013 8:03 a.m. Oct. 16, 2013 - BusinessWire
Pre-Market Review: MannKind Corp., Galena Biopharma Inc., Ariad Pharmaceuticals Inc., and Novavax Inc. 3:40 p.m. Oct. 10, 2013 - PR Newswire
Galena Biopharma Announces Oral Presentation at the American College of Surgeons Clinical Congress 2013 7:05 a.m. Oct. 7, 2013 - GlobeNewswire
Galena Biopharma to Present at the 12th Annual BIO Investor Forum 7:05 a.m. Oct. 4, 2013 - GlobeNewswire
Galena Biopharma Launches Abstral(R) (fentanyl) Sublingual Tablets for the Treatment of Breakthrough Cancer Pain 7:05 a.m. Oct. 3, 2013 - GlobeNewswire
Merger Updates, Milestone Payments, AGM Results, Review of Strategic Alternatives and Other Corporate Announcements - Research Report on Cubist, Halozyme, Taro, Galena and Sequenom 8:00 a.m. Oct. 1, 2013 - PR Newswire
Galena Biopharma Announces Closing of Over-Allotment Option, Increasing Total Gross Proceeds to $40 Million 3:22 p.m. Sept. 23, 2013 - GlobeNewswire
Galena Biopharma to Present at the 20th Annual NewsMakers in the Biotech Industry Conference 7:05 a.m. Sept. 23, 2013 - GlobeNewswire
Galena Biopharma Announces Closing of Public Offering of Common Stock and Warrants 12:52 p.m. Sept. 18, 2013 - GlobeNewswire
Five Star Equities Issues New Research Reports on DCTH, GALE, MKTO and NSPH 8:40 a.m. Sept. 16, 2013 - ACCESSWIRE
Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants 9:20 a.m. Sept. 13, 2013 - GlobeNewswire
Galena Biopharma Announces Proposed Public Offering of Common Stock and Warrants 4:05 p.m. Sept. 12, 2013 - GlobeNewswire
(0)
(0)Scroll down for more posts ▼
